Valaciclovir

6 trials 3 recruiting JAnti-infectives

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

1 Completed trials

6 Sponsors

5 Countries

Phase III

Phase II

Phase III: 4 Phase II: 2

Indications tested

End stage renal disease 1 Retinitis pigmentosa 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 1 Beacon Therapeutics (USA) Inc. 1 Centre Hospitalier Universitaire De Nantes 1 Instytut Matki I Dziecka 1 Medical University Of Vienna 1 UZ Leuven 1

All trials

6 total

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With X-linked Retinitis Pig… Not authorised

2024-511181-36-00 Phase III 1 country Beacon Therapeutics (USA) Inc.
A Clinical Trial of OM336 to Help Immunized Patients Become Eligible for Kidney Transplantation Not authorised

2025-523222-40-00 Phase II 1 country Medical University Of Vienna
Clinical trial (study) comparing the efficacy and safety of valacyclovir used in the prevention and treatment of primary cytomegalovirus (CM… Recruiting

2023-508643-46-00 Phase II 1 country Instytut Matki I Dziecka
" Prenatal treatment of congenital cytomegalovirus infection with letermovir randomized against valaciclovir (CYMEVAL III) Recruiting

2024-512869-14-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Contribution of an antiviral drug (Valaciclovir) in the treatment of generalized periodontitis (stage III or IV and grade A, B or C) Recruiting

2022-501957-35-00 Phase III 1 country Centre Hospitalier Universitaire De Nice
Treat-CMV Ended

2022-500714-25-01 Phase III 1 country UZ Leuven

Showing 1–6 of 6 trials

← All drugs A–Z